02-04-05

Proportions.JPG (67009 bytes)Scientia Veritas, L.L.P.


 


About Us        Healthcare        Toxicology        Company News        Contact Us        Search

  ScientiaVision Reports            Stroke Management Markets and Strategies

Retrieve Order

About Us

Toxicology

Company News

Healthcare

ScientiaVision

Stroke Management

TOC-LOEs

Coming Soon

Search

Advanced Search

Contact Us

Scientia Veritas announces new, low price for Stroke Management Markets and Strategies

Evergreen, CO
June 10, 2005


Scientia Veritas (SV) is pleased to announce a new, low price for its Stroke Management Markets and Strategies market research report, which was originally published in April 2003.  Update 2 to the report was published in February 2005 and is available for free download.  The update includes news concerning products in development, product approvals, company news, and mergers and acquisitions in the Stroke Management industry.  Stroke Management Markets and Strategies provides a comprehensive look at the stroke management industry, including information on trends and demographics; products and market growth for stroke prevention and treatment pharmaceuticals, stroke devices, and surgical interventions; and profiles of key competitors.

For more information or to download Update 2, please visit www.ScientiaVeritas.com/StrokeManagement.aspThe original report, published in April 2003, is 345 pages and includes 144 exhibits.  It is available in file download, CD, and hard copy formats.

To download a complete Table of Contents and List of Exhibits (free), go to www.ScientiaVeritas.com/TOC-LOEs.asp or contact us at Healthcare@ScientiaVeritas.com

Download Update 2 Here FREE!

The market for stroke diagnosis, pharmaceuticals, devices, and surgical intervention is projected to reach nearly $4.7 billion in 2005.  Stroke prevention and treatment pharmaceuticals are projected to account for the largest share of the market, at 50.3%; diagnosis will be second, at 27.0%; surgical intervention, 15.5%; and devices, 7.2%. 

About Scientia Veritas:

Scientia Veritas (SV) was founded in 1997 and offers both Healthcare and Toxicology/Risk Assessment products and services.  Our Healthcare Division publishes market research reports, writes journal articles and book chapters, develops continuing education materials for medical professionals, and performs a variety of custom work.  SV’s Toxicology/Risk Assessment Division offers products and services that include human and ecological risk assessment, development of guidance documents, expert witness testimony, toxic tort support, statistical analysis, and training and seminars.  SV provides expertise to a variety of public and private clients, including a wide range of healthcare publishing companies, physicians, pharmaceutical suppliers, medical device suppliers, the Department of Justice, Department of the Navy, and Environmental Protection Agency.

Reports coming soon include Anti-Infectives Markets and Strategies; Home Care Services Markets and Strategies; Long-Term Care Markets and Strategies; Men's Cancer Markets and Strategies: BPH, Prostate Cancer, and Testicular Cancer; Pain Management Markets and Strategies; Women's Cancer Markets and Strategies: Breast, Cervical, Endometrial, and Ovarian Cancers; and Wound Care Markets and Strategies.

Contact:       Patricia DeGrandchamp, Healthcare@scientiaveritas.com
Tel:  (303) 674-3732; Fax:  (303) 674-8755

 

Home | Search | Current Order | Saved Cart

 


Scientia Veritas, L.L.P.
5910 Northwood Drive
Evergreen, CO  80439
www.ScientiaVeritas.com
Healthcare:  (303) 674-3732;  Healthcare@ScientiaVeritas.com
Toxicology/Risk Assessment:  (303) 674-8751;  Toxicology@ScientiaVeritas.com
Fax:  (303) 674-8755